We are live on ! Find out more
IMMU

Immunomedics Inc
IMMU

Delisted

IMMU was delisted on the 22nd of October, 2020.

Back to rankings

0 hedge funds and large institutions have $0 invested in Immunomedics Inc in 2020 Q4 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 403 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% less funds holding

Funds holding: 408 → 0 (-408)

100% less funds holding in top 10

Funds holding in top 10: 68 → 0 (-68)

100% less capital invested

Capital invested by funds: $17B → $0 (-$17B)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 403

Holders
–
Holders Change
-408
Holders Change %
-100%
% of All Funds
–
Holding in Top 10
–
Holding in Top 10 Change
-68
Holding in Top 10 Change %
-100%
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
403
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
ACA
Avoro Capital Advisors
New York
-$2.23B
2
Vanguard Group
Vanguard Group
Pennsylvania
-$1.54B
3
BlackRock
BlackRock
New York
-$1.14B
4
HI
HBK Investments
Texas
-$553M
5
FCM
Farallon Capital Management
California
-$498M
Name Holding Trade Value Shares
Change 		Change in
Stake
American Century Companies
51
American Century Companies
Missouri
– -$76.6M -900,980 Closed
Wells Fargo
52
Wells Fargo
California
– -$73.2M -860,762 Closed
SCM
53
Segantii Capital Management
Hong Kong
– -$72.7M -854,406 Closed
Capstone Investment Advisors
54
Capstone Investment Advisors
New York
– -$72.3M -850,800 Closed
GCL
55
Glazer Capital LLC
New York
– -$71.7M -842,704 Closed
MAM
56
Melqart Asset Management
United Kingdom
– -$68M -800,000 Closed
GL
57
Governors Lane
New York
– -$67.2M -790,600 Closed
CC
58
Carlson Capital
Texas
– -$65.9M -775,000 Closed
New York State Common Retirement Fund
59
New York State Common Retirement Fund
New York
– -$63.8M -749,995 Closed
LP
60
LMR Partners
United Kingdom
– -$61.7M -725,957 Closed
DAM
61
DLD Asset Management
New York
– -$59.5M -700,000 Closed
WCMNY
62
Westchester Capital Management (New York)
New York
– -$57.9M -681,510 Closed
Two Sigma Advisers
63
Two Sigma Advisers
New York
– -$51.5M -605,510 Closed
RHJA
64
Rice Hall James & Associates
California
– -$51M -600,319 Closed
SAM
65
Sectoral Asset Management
Quebec, Canada
– -$51M -600,242 Closed
PSAMP
66
P. Schoenfeld Asset Management (PSAM)
New York
– -$50.6M -594,969 Closed
QF
67
QVT Financial
New York
– -$50.6M -594,700 Closed
Citigroup
68
Citigroup
New York
– -$48.3M -568,440 Closed
Voloridge Investment Management
69
Voloridge Investment Management
Florida
– -$48.3M -567,996 Closed
VI
70
Versor Investments
New York
– -$46.2M -543,327 Closed
Barclays
71
Barclays
United Kingdom
– -$45.5M -535,506 Closed
Tudor Investment Corp
72
Tudor Investment Corp
Connecticut
– -$45.1M -530,454 Closed
CS
73
Credit Suisse
Switzerland
– -$44M -517,646 Closed
ACP
74
Acuta Capital Partners
California
– -$43.5M -511,500 Closed
California Public Employees Retirement System
75
California Public Employees Retirement System
California
– -$40.1M -471,554 Closed
1 2
3
4 5

IMMU Hedge Fund Activity: Q4 2020 in Review

0 of the 5,652 institutional investors tracked by Wall St. Rank reported a position in Immunomedics Inc (IMMU) for Q4 2020, worth a combined $0 — down 100% from $17B a quarter earlier.

Sellers outnumbered buyers: 403 funds closed out of IMMU and 0 opened new positions — a net loss of 403 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was Avoro Capital Advisors, exiting entirely with an estimated $2.23B sold.

  • 0 institutional investors held Immunomedics Inc (IMMU) as of Q4 2020, down from 408 in Q3 2020.
  • Funds reported $0 of Immunomedics Inc stock for Q4 2020, down 100% quarter-over-quarter.
  • 0 funds opened new Immunomedics Inc positions in Q4 2020 and 403 closed out, a net change of -403 holders.
  • The largest Immunomedics Inc seller in Q4 2020 was Avoro Capital Advisors, an estimated $2.23B sold.

Based on aggregated 13F filings for Q4 2020.